📰 Anges Inc News
Page 5 - Anges Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anges Inc. Real-time updates on events, politics, business and more.
May 10, 2022
/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...
March 27, 2022
Brickell Biotech (NASDAQ:BBI – Get Rating) and Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent recommendations […]
March 24, 2022
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...
March 24, 2022
/PRNewswire/ -- The "Cell and Gene Therapy World Market and Market Potential" report has been added to ResearchAndMarkets.coms offering. The report examines...
February 1, 2022
The "Cell Gene Therapy Market Global Outlook Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The cell and gene therapy market size was valued at USD 4.99 billion in
February 1, 2022
/PRNewswire/ -- The "Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.coms offering. The cell and...
February 1, 2022
/PRNewswire/ -- The "Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.coms offering. The cell and...
January 14, 2022
DNA Vaccines Market report is the comprehensive market research report which studies the challenges, market structures, opportunities, driving forces, emerging trends, and competitive landscape of  industry. Moreover, the report revises general market conditions, estimates market share and possible sales volume of...
January 12, 2022
Asthma Market Outlook – Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie
January 12, 2022
Asthma Market Outlook – Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie